Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000239

EVP and CMO sold 596 shares at $482.50 ($287,570)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bozic Carmen · EVP and CMO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-26 Sale : show line 1 in the form 10b5-1 −596 $482.50 $287,570 15,337 D
Open-market sales · 596 sh · avg $482.50 · $287,570
Loading xslF345X06/wk-form4_1782850180.xml…